Evidence map›Paper›PMID 39760648›Full record

ArticleThe American journal of surgical pathology2025

Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and Mutation.

Alena Skálová, Martina Bradová, Abbas Agaimy, Jan Laco, Cécile Badual, Stephan Ihrler, Ivan Damjanov, Niels J Rupp, Carlos E Bacchi, Sarina Mueller and 12 more

Abstract read
In one paragraph

Article in The American journal of surgical pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Molecular pathology of adenoid cystic carcinoma.Histology and histopathology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Alena SkálováDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen.
Martina BradováDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen.
Abbas AgaimyInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU).
Jan LacoThe Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Cécile BadualService d'Anatomo-Pathologie, Department of Pathology, Hôpital Européen G Pompidou, APHP, Université de Paris.
Stephan IhrlerDermpath, Muenchen, Germany.
Ivan DamjanovThe University of Kansas School of Medicine.
Niels J RuppDepartment of Pathology, and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Carlos E BacchiConsultoria em Patologia, Botucatu, São Paulo, Brazil.
Sarina MuellerDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Erlangen, Erlanden.
Sami VenteläDepartments of Otorhinolaryngology.
Da ZhangDepartment of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS.
Eva ComperatDepartment of Pathology, Tenon Hospital, Sorbonne University, Paris, France.
Petr MartínekMolecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen.
Radek ŠímaDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen.
Tomas VaněčekMolecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen.
Petr GrossmannMolecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen.
Petr SteinerMolecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen.
Veronka HájkováMolecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen.
Inka KovářováDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen.
Michal MichalDepartment of Pathology, Charles University, Faculty of Medicine in Pilsen.
Ilmo LeivoPathology, Turku University Hospital.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenoid cystic carcinomas (AdCC) of salivary gland origin have long been categorized as fusion-defined carcinomas owing to the almost universal presence of the gene fusion MYB::NFIB , or less commonly MYBL1::NFIB. Sinonasal AdCC is an aggressive salivary gland malignancy with no effective systemic therapy. Therefore, it is urgent to search for potentially targetable genetic alterations associated with AdCC. We have searched the authors' registries and selected all AdCCs arising in the sinonasal tract. The tumors were examined histologically, immunohistochemically, by next generation sequencing (NGS) and/or fluorescence in situ hybridization (FISH) looking for MYB/MYBL1 and/or NFIB gene fusions or any novel gene fusions and/or mutations. In addition, all tumors were tested for HPV by genotyping using (q)PCR. Our cohort comprised 88 cases of sinonasal AdCC, predominantly characterized by canonical MYB::NFIB (49 cases) and MYBL1::NFIB (9 cases) fusions. In addition, noncanonical fusions EWSR1::MYB ; ACTB::MYB; ESRRG::DNM3 , and ACTN4::MYB were identified by NGS, each of them in 1 case. Among nine fusion-negative AdCCs, FISH detected rearrangements in MYB (7 cases) , NFIB (1 case), and EWSR1 (1 case). Six AdCCs lacked fusions or gene rearrangements, while 11 cases were unanalyzable. Mutational analysis was performed by NGS in 31/88 (35%) AdCCs. Mutations in genes with established roles in oncogenesis were identified in 21/31 tumors (68%), including BCOR (4/21; 19%), NOTCH1 (3/21; 14%), EP300 (3/21; 14%), SMARCA4 (2/21; 9%), RUNX1 (2/21; 9%), KDM6A (2/21; 9%), SPEN (2/21; 9%), and RIT1, MGA, RB1, PHF6, PTEN, CREBBP, DDX41, CHD2, ROS1, TAF1, CCD1, NF1, PALB2, AVCR1B, ARID1A, PPM1D, LZTR1, GEN1 , PDGFRA , each in 1 case (1/21; 5%). Additional 24 cases exhibited a spectrum of gene mutations of uncertain pathogenetic significance. No morphologic differences were observed between AdCCs with MYBL1::NFIB and MYB::NFIB fusions. Interestingly, mutations in the NOTCH genes were seen in connection with both canonical and noncanonical fusions, and often associated with high-grade histology or metatypical phenotype, as well as with poorer clinical outcome. Noncanonical fusions were predominantly observed in metatypical AdCCs. These findings emphasize the value of comprehensive molecular profiling in correlating morphologic characteristics, genetic landscape, and clinical behavior in AdCC.

Indexed as

Biomarkers, TumorCarcinoma, Adenoid CysticGene FusionMutationOncogene Proteins, FusionParanasal Sinus NeoplasmsAdultAgedAged, 80 and overDNA Mutational AnalysisFemaleGene Expression ProfilingGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryBiomarkers, TumorMYBL1 protein, humanNFIB protein, humanNFI Transcription FactorsOncogene Proteins, FusionProto-Oncogene ProteinsTrans-Activators

Identifiers

PMID39760648
PMCPMC11834963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.